Lansoprazole and Purinethol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lansoprazole (lansoprazole) and Purinethol (mercaptopurine). Common drug interactions include anal fissure among females and cholestasis among males.

The phase IV clinical study analyzes what interactions people have when they take Lansoprazole and Purinethol. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Purinethol?

Purinethol has active ingredients of mercaptopurine. It is often used in ulcerative colitis. eHealthMe is studying from 3,810 Purinethol users. Check the latest studies of Purinethol.



On Aug, 05, 2026

18 people who take Lansoprazole and Purinethol together, and have interactions are studied.

Lansoprazole and Purinethol drug interactions.

What are the common drug interactions of Lansoprazole and Purinethol, by gender? *:

female:

  1. Anal fissure
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  3. Haematochezia (passage of stools containing blood)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Proctalgia (pain in the rectum)
  6. Productive cough
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Arthralgia (joint pain)
  9. Asthenia (weakness)
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

male:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatomegaly (abnormal enlargement of the liver)
  3. Weight increased
  4. Hepatocellular injury (liver injury)
  5. Hyperbilirubinaemia (excess of bilirubin in the blood)
  6. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  7. Overdose
  8. Abdominal distension
  9. Drug ineffective
  10. Hepatitis acute

What are the common drug interactions of Lansoprazole and Purinethol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatomegaly (abnormal enlargement of the liver)
  3. Anal fissure
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Haematochezia (passage of stools containing blood)
  6. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  7. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  8. Proctalgia (pain in the rectum)
  9. Productive cough

20-29:

n/a

30-39:

  1. Abdominal distension
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  5. Diarrhoea haemorrhagic (bloody diarrhoea)
  6. Diplopia (double vision)
  7. Disturbance in attention
  8. Encephalitis (inflammation of the brain)
  9. Eye disorder
  10. Fatigue (feeling of tiredness)

40-49:

n/a

50-59:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatocellular injury (liver injury)
  3. Hyperbilirubinaemia (excess of bilirubin in the blood)
  4. Overdose
  5. Spinal cord injury

60+:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Septic shock (shock due to blood infection)
  3. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  4. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 5 people, 27.78%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 22.22%
  3. Respiratory Tract Infection: 3 people, 16.67%
  4. Joint Pain: 3 people, 16.67%
  5. Infection: 2 people, 11.11%
  6. Fungal Infection: 2 people, 11.11%
  7. Herpes Virus Infection: 1 person, 5.56%
  8. Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 1 person, 5.56%
  9. Depression: 1 person, 5.56%
  10. Constipation: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and Purinethol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lansoprazole and Purinethol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Purinethol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lansoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Purinethol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole and mercaptopurine (the active ingredients of Lansoprazole and Purinethol, respectively), and Lansoprazole and Purinethol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: